Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1211 Fish Hatchery Rd
Madison, WI 53715Phone+1 608-252-8000Fax+1 608-410-2905
Summary
- Adam Levin, MD, is an oncology specialist located in Milwaukee, WI. His education and training were completed at the Medical College of Wisconsin and its affiliated hospitals, beginning with his medical degree in 2014 and concluding with a fellowship in Hematology and Medical Oncology from 2018-2021. He also served as Chief Resident in Internal Medicine at the same institution from 2017-2018. He has authored numerous oncology-focused publications, with research appearing in esteemed journals like JAMA Network Open, and American Journal of Hematology, all of which have been cited by other publications multiple times. His research subjects include hematopoietic cell transplantation, chimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas, novel biomarkers in multiple myeloma, and early mortality in patients with acute myelogenous leukemia.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2018 - 2021
- Medical College of Wisconsin Affiliated HospitalsChief Residency, Internal Medicine, 2017 - 2018
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2014 - 2017
- Medical College of WisconsinClass of 2014
Certifications & Licensure
- WI State Medical License 2016 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 27 citationsNovel biomarkers in multiple myeloma.Adam Levin, Parameswaran Hari, Binod Dhakal
Translational Research. 2018-06-01 - 17 citationsChimeric antigen receptor modified T cell therapy in B cell non-Hodgkin lymphomas.Adam Levin, Nirav N. Shah
American Journal of Hematology. 2019-05-01 - 5 citationsEarly mortality in patients with acute myelogenous leukemia treated in teaching versus non-teaching hospitals: A large database analysis.Adam Levin, Ariel Kleman, Lisa Rein, Sergey Tarima, Laura C. Michaelis
American Journal of Hematology. 2017-06-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: